Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Katai

Showing results (91-100 of 195) with videos related to

Pageof 20
Sort By:
Journal of Cancer|August 1, 2022
Prognostic Impact of Long-term Postoperative Pneumonia in Elderly Patients with Early Gastric CancerAyako Kamiya, Tsutomu Hayashi, Ryota Sakon, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 13, 2006
Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry, Keiichi Maruyama, Michio Kaminishi, et al.
Journal of Gastroenterology|May 12, 2009
Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancerTakako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancerMitsuru Sasako, Shinichi Sakuramoto, Hitoshi Katai, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 3, 2019
An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasisHiroshi Katayama, Akira Tsuburaya, Junki Mizusawa, et al.
Cells|June 19, 2019
Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived XenograftsTakeshi Kuwata, Kazuyoshi Yanagihara, Yuki Iino, et al.
Journal of the American College of Surgeons|September 11, 2010
Large-scale investigation into dumping syndrome after gastrectomy for gastric cancerShinji Mine, Takeshi Sano, Kenji Tsutsumi, et al.
Gastroenterology|November 5, 2003
The genomic damage estimated by arbitrarily primed PCR DNA fingerprinting is useful for the prognosis of gastric cancerKoichi Suzuki, Sumiko Ohnami, Chikako Tanabe, et al.
Journal of Surgical Oncology|February 13, 2013
Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)Yoshiaki Iwasaki, Mitsuru Sasako, Seiichiro Yamamoto, et al.
Carcinogenesis|July 26, 2020
Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathwaysMenghan Yang, Eri Arai, Yoriko Takahashi, et al.
Pageof 20

Showing results (91-100 of 195) with videos related to

Sort By:
Pageof 20
Journal of Cancer|August 1, 2022
Prognostic Impact of Long-term Postoperative Pneumonia in Elderly Patients with Early Gastric CancerAyako Kamiya, Tsutomu Hayashi, Ryota Sakon, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 13, 2006
Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry, Keiichi Maruyama, Michio Kaminishi, et al.
Journal of Gastroenterology|May 12, 2009
Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancerTakako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancerMitsuru Sasako, Shinichi Sakuramoto, Hitoshi Katai, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 3, 2019
An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasisHiroshi Katayama, Akira Tsuburaya, Junki Mizusawa, et al.
Cells|June 19, 2019
Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived XenograftsTakeshi Kuwata, Kazuyoshi Yanagihara, Yuki Iino, et al.
Journal of the American College of Surgeons|September 11, 2010
Large-scale investigation into dumping syndrome after gastrectomy for gastric cancerShinji Mine, Takeshi Sano, Kenji Tsutsumi, et al.
Gastroenterology|November 5, 2003
The genomic damage estimated by arbitrarily primed PCR DNA fingerprinting is useful for the prognosis of gastric cancerKoichi Suzuki, Sumiko Ohnami, Chikako Tanabe, et al.
Journal of Surgical Oncology|February 13, 2013
Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)Yoshiaki Iwasaki, Mitsuru Sasako, Seiichiro Yamamoto, et al.
Carcinogenesis|July 26, 2020
Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathwaysMenghan Yang, Eri Arai, Yoriko Takahashi, et al.
Pageof 20